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Although it is known that complement combines with most antigen-antibody 
compounds, the r61e of the components of complement in  this union  is not 
clearly understood. 
It is generally stated that  the mid-piece of complement is the combining 
component (1, 2).  On the other hand,  Brin states that the end-piece alone is 
fixed (3).  Others assert that both the end-piece  and mid-piece  combine with 
antigen-antibody  compounds  (4-7).  Deissler  (8)  contends  that  the  fourth 
component of complement is utilized in complement fixation.  Some workers 
claim to have confirmed this statement (9, 10), while others contradict it (11). 
The present authors,  in experiments preliminary  to those reported in this 
paper, found indications that the fourth component and end-piece,  as well as 
mid-piece in a smaller proportion, combine with antigen-antibody compounds. 
There  are  several reasons for the various views of others.  (1)  With  the 
exception of a few recent studies, investigations on the rSle of the complement 
components in fixation were performed before the discovery of the fourth com- 
ponent of complement.  (2)  Uniform methods for the preparation and identi- 
fication of the individual  complement components were not employed.  (3) 
Much of the past work was qualitative in nature with little consideration of 
the physical and chemical  conditions which affect the combination of comple- 
ment with antigen-antibody aggregates.  (4)  The results obtained under one 
set  of experimental  conditions  were  frequently  interpreted  to  fit  all  other 
conditions. 
The need for more rigidly controlled studies on complement fixation  is evi- 
dent; and accordingly the present paper is concerned first with the conditions 
governing the fixation of the components of complement; and second with the 
identification of those components of complement which combine with specific 
antigen-antibody compounds. 
*Aided by a grant'from the Commonwealth Fund. 
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R~sum~ of the Nature of the Components of Complement 
To assist in the interpretation  of the data presented in this paper, a  review 
of the existing knowledge of the constitution of complement is necessary.  A 
more detailed  discussion has been presented elsewhere  (12). 
Complement can be separated  into two  thermolabile  components  (destroyed by 
heating at 56  ° for 30 minutes) by treatment of serum with carbon dioxide-saturated 
water or dilute HC1, or by dialysis against distilled water (1).  Accompanying each 
of these fractions are varying amounts of two relatively thermostabile components of 
complement, the third and fourth components.  The fraction of fresh serum insoluble 
in a tenfold dilution of carbon dioxide-saturated water has been termed the "globulin 
fraction" or the "mid-piece," while the fraction soluble in the same medium has been 
termed the "albumin fraction" or "end-piece."  The terms mid- and end-piece were 
formulated by the early investigators because they supposed that the carbon dioxide- 
insoluble fraction had first to combine with the sensitized red blood ceils before the 
albumin fraction would act.  It is also known that either cobra venom or yeast ceils 
destroys a  relatively heat-stable component (inactivated by heating at 66°C. for 30 
minutes)  which has been termed the third component (1).  It is usually associated 
with the globulin fraction of serum, although, as will be shown below, it is also nearly 
always present in the end-piece.  PiUemer and Ecker (13), investigating the nature 
of the yeast inactivation of the third component, isolated an insoluble fraction from 
yeast  which adsorbs  the  third  component specifically from fresh  serum.  Certain 
unpublished data are indicative of a  lipid nature of this component (14).  A fourth 
component of complement, inactivated by dilute ammonia, has also been discovered 
(1).  It is usually associated with the end-piece, but, as will be shown below, under 
certain experimental  conditions it also is often present in the mid-piece fraction of 
complement.  Pillemer, Seifter, and Ecker (15) postulated that this component con- 
tains a reactive carbonyl group and is associated with a globulin fraction present in 
the so called albumin fraction. 
PiUemer, Ecker, Oncley, and Cohn (16) have prepared in a  highly pure state, and 
characterized,  three of the components of complement.  The mid-piece was found 
to be a euglobulin with an apparent isoelectric point of about 5.2.  It has an electro- 
phoretic mobility of 2.9  ×  10  -5 in a  phosphate buffer of an ionic strength of 0.20 
at pH 7.7; and a sedimentation constant of 6.4  X  10  -x3 in KC1 of ionic strength of 
0.20.  It comprises only 0.60 per cent of the total serum protein; and each cubic centi- 
meter of serum contains 0.060 nag. of mid-piece nitrogen.  The end-piece and fourth 
component were found in  the same serum fraction, which was  characterized as a 
muco-euglobulin with an apparent isoelectric point of 6.3--6.4, and with an electro- 
phoretic mobility of 4.2  ×  10  -5.  It contains 10.3 per cent carbohydrate; and it com- 
prises less than 0.2 per cent of the total serum protein, thus accounting for 0.02 rag. 
of  nitrogen  per  co.  of  serum. 
Pillemer and Ecker (17) on the basis of electrophoretic and functional studies, and 
Heidelberger  (18, 22)  have proposed a  new nomenclature for the complement com- 
ponents.  The symbols CO, Ct2,  C~3, and Cr4, which correspond to the mid-piece, 
end-piece,  third component, and fourth component respectively in the older termi- L.  PILLEMER~  S.  SEIFTER~  AND  E.  E. ECKER  423 
nology, were adopted.  In the present paper the terms mid-piece and CO2-insoluble 
fraction are used interchangeably, as are end-piece and  CO~-soluble fraction;  and 
the symbols C'I and C'2 represent the mid-piece and end-piece components per se. 
The terms third and fourth components are used interchangeably with  the symbols 
C'3 and C'4 respectively. 
Materials 
Complement.--The  blood of normal guinea pigs which had been  maintained on a 
high vitamin C diet was placed in the ice box for about one hour.  At the end of this 
time the serum was separated by centrifugation and immediately used in the experi- 
ments.  In the protocols which follow, the serum, unless otherwise noted, was never 
allowed to stand more than one hour before use in fixation experiments. 
Antigens.--Type III pneumococcus specific carbohydrate was used in the larger 
part of  the experimental work.  A stock solution of  0.1  per cent  sni  x in 0.9 per 
cent saline was diluted with 0.9 per cent saline to the desired concentration. 
Human serum, hemocyanin (from Busycon canaliculata), tobacco mosaic virus, and 
red blood cells of various species were also employed as antigens3  The amounts 
employed are indicated in the protocols. 
Antisera.--A refined anti-Type III pneumococcus  rabbit serum  containing 4.57 
nag. of antibody nitrogen per cc. was kindly furnished by the Lederle Laboratories, 
Inc.  It was not anticomplementary in twice the quantities employed in the present 
experiments. 
Antihuman rabbit serum, antihemocyanln rabbit serum, antitobacco mosaic virus 
(rabbit) serum, and rabbit antisera to red blood cells of sheep, dog, guinea pig, and 
man  were also employed.  Since the latter sera were found to be somewhat anti- 
complementary in the amounts necessary for optimum fixation, the procedure advo- 
cated by Sachs (19) was employed to remove the objectionable substances from them. 
This was successfully accomplished without much loss of the fixative powers of the 
antisera. 
Chemicals.--All  chemicals used were either best grade Eastman or Merck's blue 
label chemicals.  Unless otherwise noted, all dilutions were made with 0.9 per cent 
NaCI.  The  insoluble carbohydrate from  yeast  used  in  the  removal  of  C'3  was 
prepared by the method of Pillemer and Ecker (13). 
Methods 
General Method for Fixation.--To A cc. of antiserum, B cc. of undiluted fresh serum 
were added with thorough mixing.  The mixture was then brought to the desired 
temperature, tonicity, and hydrogen ion concentration.  C cc. of antigen, adjusted to 
the desired experimental conditions, were then added rapidly with constant stirring. 
I S  with the appropriate numeral is used for the type-specific polysaccharide of 
the pneumococcus. 
9. We are indebted to Dr. M. Heidelberger for a generous supply of anti-Type III 
pneumococcus rabbit serum; to Dr. S. B. Hooker for hemocyanin and antihemocyanin 
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The mixture was allowed to stand for the prescribed time at the required temperature. 
Following this incubation the mixture was centrifuged for 30 minutes at 2750 R.P.•.; 
and the clear supematant was drawn off carefully with a  pipette, adjusted to the 
required conditions, and finally made up with 0.9 per cent NaCI to a  10 per cent 
dilution of the original guinea pig serum.  This solution was tested for hemolytic 
activity, and if found not to show more than 10 per cent of its original activity it was 
further tested for content of individual complement components. 
Complement Titration.--A unit of complement, designated as producing 100  per 
cent hemolysis, was considered to be the smallest amount of a  10 per cent dilution of 
untreated serum which caused complete hemolysis of 1 cc. of 2.5 per cent suspension 
of sheep red blood corpuscles containing 5 units of antisheep cell rabbit serum per cc. 
An identical amount was employed in all reactivations and complement component 
determinations. 
Estimation of the Individual Component Activity in Fixed Complements.--A unit of 
the complement rendered inactive by fixation was added to an equal amount of each 
of the specifically  inactivated complement components described below.  The mixture 
was incubated at room temperature for 15 minutes, 1 cc. of sensitized sheep red cell 
suspension added, and  the hemolytic titer read after 30  minutes of incubation at 
37.5°C.  The amount  of hemolysis produced was estimated by comparison with a 
series of standard hemoglobin solutions, and  expressed as percentage of complete 
hemolysis. 
It is pointed out that the data presented in this paper do not indicate the absolute 
quantity of each component present, but only represent the residual activity present 
after fixation or specific inactivation. 
For the further clarification of the data, the per cent hemolysis resulting from the 
inter-reactivations  of  the  "specifically inactivated  complements"  (see  below)  is 
included in each protocol. 
Success in the reactivations depends largely on preventing the loss of activity of 
the complement components which might occur during the course of an experiment. 
Therefore, all serum reagents should be kept at 0°C. (:t:1  °) until they are to be used. 
Precautions of this kind are necessary for obtaining comparable, reproducible data. 
Furthermore, slight deviations from any technique described here may alter the end- 
result of an experiment. 
In the interpretation of data on hemolysis no significance is attached to differences 
of 10 per cent hemolysis or less, because of the proscribed limit  of accuracy of the 
method. 
The Preparation of Complements Deprived of Various Components 
These  are  hereafter  designated  "specifically inactivated  complements." 
1.  Complement was deprived of active Ct4 by appropriate treatment of serum with 
hydrazine or ammonia (15, 20). 
2.  Complement was  deprived of  Ct3  by treatment  of serum with zymin or the 
insoluble carbohydrate prepared from fresh yeast (13). 
3.  Complement was deprived of C'I and C'2 activity by heating serum at 56°C. 
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4.  The CO,-soluble  and  CO~-insoluble fractions  were prepared by  saturation  of 
diluted  serum with  COs as described elsewhere (12).  While this  method  results in 
the sharp separation  of C'1 and C'2 from one another, marked variation occurs in the 
distribution  of C'3 and CP4 in the fractions.  The CO~-soluble fraction  or end-piece, 
contains all of the active CP2, usually from 70 to 100 per cent of the C~4, and from 20 
to 40 per cent of the C'3.  The CO2-insoluble fraction,  or mid-piece, contains  all of 
the C'1, usually about 60 to 80 per cent of CP3, and from 0 to 30 per cent of the CP4. 
In this  laboratory it is believed that the residual  C'4 manifest  in  the mid-piece is 
accompanied by a small amount of C~2, since it is the opinion here that C'2 and C'4 
are associated in the same guinea pig serum protein constituent. 
EXPERIMENTAL 
Factors Which Influence  the Fixation  of the Components of Complement.--In 
these  experiments  complement fixation  was  carried  out  with  anti-Type  III 
pneumococcus rabbit  serum  compounds. 
1.  The Effect of Aging of Complement.-- 
A pool of fresh guinea pig serum was divided into two portions,  one of which was 
allowed to incubate  for one hour with the specific antipneumococcus  complexes, at 
the end of which time the fixability of the complement  components was determined. 
The second portion of serum was allowed to stand for 19 hours in the ice box (5°C.) 
and was tested in a like manner.  The serum lost 50 per cent of its complementary 
activity during the 19 hours in the cold.  Complete hemolysis was brought about by 
0.07 co. of 10 per cent dilution  of fresh serum, while 0.14 ce. of 10 per cent  dilution 
of aged serum was required. 
The results of this experiment, performed in quintuplicate, are tabulated in 
Table I.  An inspection of the data shows that when serum stood for 19 hours 
and lost 50 per cent of its complementary activity the following changes in the 
fixability of the complement components occurred: (a) C'4 became more resis- 
tant to fixation; (b) CP3 underwent no change in fixability; (c) there was less 
reactivation  upon  the  addition  of the  COs-insoluble  fraction,  and  increased 
reactivation upon the addition of the  COs-soluble fraction in the case of the 
aged serum. 
Most investigators have allowed complement to age or "cure" in an ice chest 
overnight before using it in fixation experiments  (18,  21); however, it is ap- 
parent from the data presented here that this procedure may lead to serious 
error  in  the  determination  of  the  fixability  of  the  various  components  of 
complement.  In this laboratory, therefore, it is the practice to allow serum 
complement to stand not more than  one hour before use in fixation experi- 
ments. 
2.  The  Effect  of  Time  of Incubation.--An  experiment  was  performed  to 
determine  the  optimum time  necessary for the fixation  of the  various com- 
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The reagents were mixed as described in the section  of this paper dealing with the 
general method of fixation, and were allowed to stand at  25°C. for different  periods 
of time.  At the end of the allotted time the residual complement component activities 
were determined.  In order to avoid occlusions and uneven distribution of  reagents, 
separate tubes were employed for each incubation. 
TABLE I 
The Effect of Aging on the Fixation of Complement 
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0.2 
0.2 
0.2 
0.2 
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0.2 
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0  0 
0  0 
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I 
40 
40  15 
1  0.2 
1  0.2 
1  0.2 
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complements 
Serum  treated  with 
hydrazine ............ 
Serum  treated  with  in- 
soluble carbohydrate... 
,Serum  heated  at  56°C. 
for 30 rains .......... 
"End-piece" ........... 
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I  I 
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0 
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0  80 
0  80 
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40 
50  i 60 
50  60 
60  50 
80  60 
60  35 
40  25 
6O  5O 
80  9O 
60  35 
0  0 
0  0 
65 
65 
65 
40 
40 
45 
40  60 
60  60 
0  0 
85  90 
15  125 
15  I 25 
15  30 
9O  9O 
40  25 
0  0 
85  9O 
* I, fresh sera. 
II, sera after standing 19 hours at 5°C. 
The results of this experiment show that C'4 was fixed in the first 5  minutes 
of incubation and remained fixed for the duration of the 80 minute incubation. 
Maximum  fixation of mid-piece occurred after 40 minutes of incubation; while 
little or no variation in the fixation of end-piece occurred that could be attrib- 
uted to the effect of time of incubation.  On the basis of these data an incuba- 
tion  time  of  60  minutes  was  chosen  as  the  optimum  time  to  be  used  in  the 
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3.  The Effect of Temperature.--Although earlier workers (23, 24) determined 
the optimum temperature for the fixation of complement (considered as a single 
entity),  no knowledge exists  concerning the  influence of temperature  on the 
fixation  of  the  individual  components  of  complement.  The  results  of  an 
experiment performed to determine  the effect of temperature on the fixation 
of the  individual  components reveal  that maximum fixation of all  the  com- 
TABLE II 
The Effect of Varying Hydrogen Ion Concentration on the Fixation of Complement 
Relative quantity 
pH*  and appearance  of 
precipitate 
5.3  + +  + +  plaque 
6.1  + + +  plaque 
7.0  + +  granular 
7.1  + +  granular 
8.1  + +  granular 
8.8  + +  plaque 
Specifically inactivated 
complements 
Serum treated with hydrazine.. 
Serum treated with zymin  ..... 
Serum heated  at  56°C. for 
30 mins,. 
"End-piece". 
"Mid-piece". 
Hemolysis 
~roduced 
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natant  Serum 
after  treated 
fixation  with 
hydrazine 
p~¢ent 
o 
o 
o 
o 
o 
o 
Hemol- 
ysis 
per cent 
o 
o 
o 
o 
o 
Hemolysis  produced after addition of specifically inactivated 
complements 
per cent 
15 
15 
0 
0 
0 
0 
Ser~zt3 
treated 
with 
zymin 
peYc6'nt 
15 
2O 
6O 
4O 
5O 
5O 
Seruln 
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56°C. for 
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p~cent 
2O 
2O 
0 
0 
0 
0 
CO  J-soluble 
fraction 
("end- 
piece") 
p~ ctnt 
50 
45 
35 
15 
25 
25 
m 
7O 
90 
90 
0 
70 
80 
25 
60 
90 
80 
m 
o 
0 
90 
25 
o 
85 
CO~- 
insoluble 
fraction 
("mid- 
piece") 
p~C~t 
o 
o 
o 
o 
o 
o 
0 
60 
o 
85 
* 1 cc. of guinea pig serum was fixed by the aggregate from 0.2 cc. of 1:4 antipneumococcus 
rabbit serum and 0.2 cc. of 1 : 10,000 SIII.  All reagents were made up to volume with phos- 
phate buffers of ionic strength 0.15.  The pH indicated here is the pH of the supernatants 
after fixation. 
portents occurred at 22°C.  Although slight differences in the fixability of the 
components were evident at 0 ° and 22 °, marked differences occurred as between 
these  temperatures  and  37°C.  At  the  latter  temperature  C'4  was  more 
resistant to fixation.  On the basis of these data further fixation experiments 
were conducted at temperatures between 20 and 25°C. 
4.  The Effect of Hydrogen Ion Concentration.--The  results of an experiment 
to determine the effect of hydrogen ion concentration on the fixation of the 
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In this experiment all  reagents  were either diluted or made up to volume with 
phosphate buffers of various hydrogen ion concentrations and of ionic strength 0.15. 
The complement was incubated with the antigen-antibody complexes for one hour at 
a  temperature  of  23°C.  Before  determination  of  their  complement  component 
activities the supematants were adjusted to a  neutral pH with 0.1  N HC1 or 0.1 
N NaOH. 
Table II shows the following: (a) at pH's below 7.0, less fixation of CP4 and 
Cq occurred than at pH 7.0, but there was an enhancement of the fixation of 
C~3; (b) at pH's above 7.0 up to 8.8 there occurred complete fixation of Ct4 
together with an  increased fixation of C'I; and  (c)  optimum fixation of the 
components of complement occurred at neutral pH's. 
In  this  experiment  the  CO,-insoluble  fraction contained no  C~4; and  no 
reactivation resulted upon the addition of CO~-insoluble  fraction to complement 
rendered inactive by fixation.  This demonstrates that C'2 was bound along 
with C~4.  If, however, C~4 is present in the CO~-insoluble  fraction, reactiva- 
tion by the latter of fixed sera in which no C'4 and C~2 can be demonstrated, 
is due to the presence of small amounts of C~2 in the CO2-insoluble fraction. 
Another point of interest evident from the experiment is that complementary 
activity was removed by specific aggregates over an extremely wide pH range, 
although  there was marked variation in the fixation of the  individual  com- 
ponents at different pH's.  On the basis of these data all other fixation experi- 
ments were conducted at pH's between 7.0-7.2. 
5.  The Effect of Tonicity.--Although the effect of varying salt concentration 
on the fixation of complement is well known (21), nothing is known of the effect 
of variations of tonicity on the fixation of the  individual complement com- 
ponents.  The results  of an experiment performed to  determine  this  effect 
revealed the following: (a) complement in slightly hypertonic NaC1 solutions 
was fixed incompletely; and (b) complement in hypotonic NaC1 solutions was 
fixed completely with little or no variation in the fixation of the individual 
components. 
CaC12 is known to interfere with complementary activity (1), and is further 
known  to  interfere with  certain  adsorption  reactions  (25).  An  experiment 
performed to show the effect of CaC12 on the fixation of the components revealed 
the following points: (a) in amounts over 0.2 per cent, CaCl~ interfered with 
the fixation of C~4 and Cq; and (b) in all amounts used CaC12 did not influence 
the fixation of C~3. 
6.  The Effect  of Propionaldehyde.--Pillemer,  Seifter, and  Ecker  (15)  have 
shown that propionaldehyde protects the fourth component from inactivation 
by hydrazine.  Since the direct and immediate inactivation of complement by 
specific  aggregates  appears  to involve  C~4, experiments  were  performed  to 
determine if propionaldehyde would  interfere with  the fixation of the  com- 
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that propionaldehyde in amounts far greater than that needed to oppose the 
anti-C'4  effect  of  hydrazine  failed  to  inhibit  the  fixation  of  complement. 
However, slightly less C'4 was fixed in the presence of propionaldehyde, while 
there was no interference with the fixation of the other components. 
7.  The Effect of Dilution  of Complement.--Table  IV summarizes the results 
of an experiment undertaken to determine the fixability of the components of 
complement which  had  been  diluted previous to fixation.  The  table shows 
TABLE III 
The Effect of Propionaldekyde on the Fixation of Complement 
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that: (a) the fixation of C'4 was inhibited only in very large dilution; and (b) 
there was an increase of fixation of the mid-piece and end-piece on dilution. 
8.  The  Effect  of Varying  Amounts  of Complement.--The  results  of  an  ex- 
periment performed to determine the variations which occur in the fixation of 
the complement components when increasing amounts of complement are added 
to  a  standard  amount  of  antigen-antibody aggregate,  show  that  increasing 
amounts of complement resulted in a  slight increase in the fixation of C'4; a 
marked decrease in the fixation of C'I; and little or no variation in the fixa- 
tion of C'3. 
9.  The Effect of Varying Amounts of Antigen and Antibody.--The  results of 430  COMPLEMENT  COMPONENTS IN SPECIFIC ~WM'UN'E FIXATION 
an experiment dealing with the effects of varying amounts of antigen and anti- 
body on  complement fixation,  show  the  following:  (a)  in  extreme  excess  of 
antigen or antibody the fixation of complement or its individual components 
was markedly inhibited; (b) when very dilute solutions of antigen and antibody 
were used C~4 did not fix completely; (c) a slight excess of antibody resulted in 
maximum fixation of the combining components of complement.  Therefore, 
in the experiments reported here, antibody was employed in a  slight excess. 
TABLE IV 
The Effect of Dilution on the Fixation of Complement 
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0.2 
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0.2 
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1 
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0 
0 
0 
0 
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inactivated complements 
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6O 
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0 
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0 
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0 
COs- 
soluble 
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("end- 
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5O 
3O 
2O 
20 
2O 
2O 
COz- 
insoluble 
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piece") 
percent 
70 
50 
30 
30 
Tr. 
Tr. 
Specifically inactivated complements 
Serum treated with hydrazine.. 
Serum  treated with insoluble car- 
bohydrate. 
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per ce~J 
0 
0 
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0 
0 
60 
70 
90 
50 
60 
60 
35 
90 
70  95 
60  35 
--  0 
0 
0  95 
5O 
9O 
0 
95 
The Fixation of Normal Guinea Pig Complement and Specifically Inactivated 
Guinea Pig Complement.--In order to determine whether the removal of one or 
more components of complement interferes with the fixation of the remaining 
components, an experiment such as the one summarized in Table V was carried 
out.  In  this  experiment  normal  complement  and  specifically  inactivated 
complements were added to the specific aggregates of Type III pneumococcus 
specific substance.  The table reveals the following points:  (1)  Almost all  of 
C~4, 25 per cent of C'3, 75 per cent of C'1, and nearly all of C'2 were removed 
or inactivated during fixation of normal complement.  This is at variance with L.  PLLLEMER,  S.  SEIFTER,  AND  E.  E.  ECKER  431 
the assumption  of most  workers  that  the  mid-piece is the  single combining 
component, as all of the components were fixed in varying amounts under the 
conditions of the  experiment.  (2)  Inactivation of  Cr4  by hydrazine  or  the 
TABLE V 
The Fixation  of Normal  and  Specifically  Inactivated  Guinea  Pig Complements 
ao 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
CC. 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
[  1 cc. of various serums 
i  or serum fractions 
! 
i 
Guinea pig serum 
Serum treated with 
hydrazine 
i Serum  treated  with  in- 
soluble carbohydrate 
Serum  treated  with  hy- 
drazine  and  insoluble 
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Serum heated at 56°C. for 
[  30 rains. 
End-piece 
Mid-piece 
Hemolysis produced after addition of specifically 
inactivated complements 
Sertma  Serum  Hem.ol-  treated 
ysm 
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fixa-  treated '  with  at  zme  "End- 
tion  with  insolu-  56oc.  and  piece" 
hydra-  ble  for 30  insoin- 
zine  carbo-  rains,  ble 
hydrate  carbo- 
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Per  per cent ! per cent  per c¢~  per cent  per c~ 
cent 
0  5  65  10  10  20 
0  0  80  0  0  Tr. 
0  10  Tr.  0  0  0 
0  0  10  0  0  0 
0  95  90  0  75  0 
0  95  40  0  40  0 
0  0  40  0  0  0 
"Mid- 
piece" 
Tr. 
0 
0 
0 
0 
45 
0 
Specifically inactivated complements 
Serum treated with hydrazine  ..... 
;erum  treated with insoluble carbo- 
hydrate .... 
Serum treated with insoluble  carbo- 
hydrate and hydrazine. 
~erum heated at 56°C. 30 mins  ........ 
'End-piece". 
'Mid-piece". ........................ 
Hemol- 
ysis 
per  cent 
0 
0 
0 
0 
0 
0 
65 
0 
90 
90 
0 
65 
10 
90 
45 
60 
90 
90 
60 
0 
0 
0 
10 
0 
60 
25 
0 
95 
45 
25 
0 
0 
90 
60 
0 
0 
90 
0 
removal of C'3  by the  insoluble carbohydrate from yeast  did not markedly 
influence the fixation of the other components.  (3) The inactivation of both 
C'I  and  C'2 by heat inhibited the fixation of C'4 and  C'3.  (4)  When end- 
piece, which contained Ct2, Ct4, and a  small amount of C'3 was added to the 
specific aggregates, no fixation of C~3 and C~4, and partial inactivation of C~2 
resulted.  Although, C"I is fixed in  the absence of  Ct4, functionally in so far 432  COMPLEMENT  COMPONENTS  IN" SPECIFIC  ~  FIXATION 
as hemolysis  is  concerned,  it is  inactive.  In studies on the  mechanism of 
immune hemolysis (26), it will be shown that unless C'4 is either fixed previ- 
ously to or simultaneously with C'I, no hemolytic activity occurs.  (5) All of 
C'1 but only a small amount of C'3 were removed in the fixation of mid-piece 
which contained all of C'1 and the major portion of C'3. 
The results of many experiments  similar  to the one above show that the 
direct and immediate inactivation of complement  which occurs in fixation is 
due to the fixation of almost all of C'4 and C'2 and of a part of C'1.  C'3 does 
not appear to play a major part in such fixation reactions.  However, it appears 
that the inactivation of the thermostable components (C'4 and C'3) does not 
interfere  with  the  fixation of  the  thermolabile  components  (C'1  and C'2). 
Further, in the absence of  mid-piece, C'2  and C'4 are not adsorbed or inac- 
tivated by fixation; while in the absence of C'2 and C'4, C'1 is still adsorbed by 
specific aggregates.  The full significance of these  results will be elaborated 
in a  subsequent  paper  dealing  with immune hemolysis  since  they are  best 
interpreted when a visible reaction, such as hemolysis, occurs. 
The Fixation of the Components by Complement by Various Antigen-Antibody 
Systems.--In order to determine whether the nature of the antigen influences 
the fixability of the components of complement,  a  series of experiments  was 
conducted in which antigens of different characteristics  and molecular  sizes 
were used. 
The components of complement were fixed quite similarly by human serum- 
antihuman rabbit serum, tobacco mosaic virus-antitobacco  mosaic virus rabbit 
serum,  and by hemocyanin-antihemocyanln rabbit  serum aggregates.  The 
fixation of  the  components  by  these  systems was  qualitatively similar  to 
fixation by SIII-antipneumococcus Type III rabbit serum (Table  V). 
Since sensitized red blood cells of different species are commonly employed 
in the assay of complementary activity, an  experiment  was  performed  in 
which complement was allowed to fix to the specific aggregates of sheep, dog, 
human, and guinea pig erythrocytes  at 1  ° C.  The results obtained were similar 
to  those described  for other aggregates,  except  for a  few minor deviations. 
Whereas the fixation of C'4-C'2 in these cases was almost identical with their 
fixation by other  systems,  C'3 appeared not to be adsorbed  at all.  Marked 
variations occurred in the amounts of C'I which combined with the different 
red blood  cell aggregates,  as expressed in the following order: guinea pig  > 
sheep  >  human >  dog. 
DISCUSSION  AND  SIJ-M~ARY 
From the experiments  reported here it is evident that the amount of each 
complement  component  which  combines  with  specific immune  aggregates 
depends upon a number of factors, including the age of the complement; the 
concentrations  of  antigen,  antibody, and  complement;  hydrogen  ion  and 
electrolyte concentrations; and time and temperature of incubation for fixation. L. PILLEM'EI~, S. SEIF~EI~, AND E. E. ECKEI~  433 
The experiments also reveal the following: 
1.  C~4 must be considered a combining component of complement because 
it is invariably inactivated or adsorbed by specific aggregates. 
2.  C~3, although necessary for the final action of complement, e.g., hemolysis 
or bactericidal action, is fixed only partially or not at all by antigen-antibody 
compounds. 
3.  C~2 is fixed together with C'4,  as is evident from those experiments  in 
which reactivations were conducted with a CO2-insoluble fraction which con- 
rained no Ct4 activity. 
4.  Mid-piece, which contains C~1, generally stated to be the single combining 
component of  complement,  is  adsorbed  by  immune  aggregates  in  varying 
amounts depending on the experimental conditions employed. 
5.  No inactivation or adsorption of C~4 and of C~3 occurs upon the addition 
to specific aggregates  of serum which has been heated at 56°C. for 30 to 50 
minutes.  This indicates that certain thermolabile constituents of serum are 
necessary for the fixation of C~4.  Inactivation of C~4 by hydrazine or the 
removal of C'3 by the insoluble carbohydrate from yeast does not markedly 
influence the fixation of the other components. 
6.  The assumption that the mid-piece is the single combining component of 
complement is further questioned for the following reasons. 
First, C~4 in fresh, untreated serum combines with specific aggregates,  but 
C~4 in heat-inactivated serum does not.  It is, therefore,  apparent that a part 
of the combining complement must be attributed to C~4 and its carrier C'2. 
Second, it will be shown in a subsequent paper that C'1, heated at 56°C. for 
45 minutes, combines with specific immune complexes, and in doing so may in 
fact inhibit the further combination of the components of untreated comple- 
ment.  This effect, first noted by Ehrlich and Sachs (27), is termed a "com- 
plementoid" action.  Thirdly, it will also be shown on the basis of quantitative 
nitrogen data (28), that the combining nitrogen, in those instances  in which 
large amounts of serum are added to a constant amount of aggregate,  should 
for the most part be attributed to C'4 and its carrier C'2. 
7.  The nature and the molecular size of the antigen does not influence the 
qualitative picture of fixation of the complement components. 
8.  While it is tempting to speculate  on the mechanism of complement fixa- 
tion, it probably is advisable that such speculation be postponed until experi- 
ments similar to those reported here are performed with purified components. 
However, certain differences between the fixation  of the  complement com- 
ponents to  specific aggregates  and  the  adsorption  of  these  components to 
non-specific agents, are apparent.  For example,  in specific immune fixation 
Ct4, C~2, and varying amounts of Ctl are fixed, while in non-specific adsorption 
both to inorganic adsorbents (29) and to untreated bacteria (30, 31), no fixation 
of C~4-CP2 occurs while all of the other components of complement are ad- 
sorbed.  Furthermore, C~3  is bound only partially or not at all to specific 434  COMPLEMENT  COMPONENTS  IN  SPECIFIC  ~  FIXATION 
aggregates,  while  it  is  completely adsorbed  or  inactivated  by  non-specific 
adsorbents.  It appears,  therefore, that the highly reactive component, C'4, 
is directly and immediately involved in specific immune fixation. 
9.  A very small amount of specific immune aggregate combines with a large 
amount of complement; whereas a large amount of non-specific agent adsorbs 
only a  small amount of complement.  This difference is undoubtedly due to 
the marked chemical affinity of C'4-C'2 and C'1 for the surfaces presented by 
immune aggregates. 
10.  It can be now stated that when complement exerts its activity in hemo- 
lytic, bacteriolytic, or bactericidal reactions, C'4-C'2 and varying amounts of 
C'1 must first combine (fix) with the antigen-antibody compound in question; 
and that any secondary  manifestation is dependent both on the adjunctive 
action of the unbound C'3 (26) and on the nature of the substrate employed. 
The chemical and immunological implications of these results will be further 
elaborated in subsequent papers. 
We wish to express our gratitude to Dr. Michael Heidelberger for his critical review 
of this paper. 
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